Search clinical trials for: Candesartan 32mg

Total 669 results

HK inno.N Corporation

Completed

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy

Essential Hypertension

Korea, Republic of
GlaxoSmithKline

Completed

A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Korea, Republic of, Malaysia, Philippines, Thailand, Russian Federation, Mexico
AstraZeneca
Takeda

Completed

DIabetic Retinopathy Candesartan Trials. (DIRECT)

Type 1 Diabetes
Slovak Academy of Sciences

Unknown

Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker (ADIRAS)

Hypertension

Slovakia
AstraZeneca
Takeda

Completed

Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France (SISTOLA)

Heart Failure | Cohort Study

France
Mitsubishi Tanabe Pharma Corporation

Completed

Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects

Chronic Kidney Disease | Hyperphosphatemia

United Kingdom
AstraZeneca

Completed

Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients

Primary Hypertension

Romania
Bayer

Completed

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension (DISTINCT)

Hypertension, Essential

Spain, Argentina, United States, Canada, Korea, Republic of, Italy, Russian Federation, South Africa, Ukraine, Belgium, Brazil, Lithuania, United Kingdom
Can-Fite BioPharma

Completed

CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis

Plaque Psoriasis

Israel, Serbia, Romania, Croatia, Bosnia and Herzegovina, Bulgaria, Canada, Moldova, Republic of, Poland
University of Helsinki
AstraZeneca

Unknown

The Potential of Candesartan to Retard the Progression of Aortic Stenosis (ROCK-AS)

Aortic Valve Stenosis

Finland
Bayer

Completed

Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, Fed

Hypertension, Essential

Germany
HK inno.N Corporation

Unknown

A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

Essential Hypertension

Korea, Republic of
Kaiser Permanente
University of California, Davis

Withdrawn

Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis C

Hepatitis C

United States
AstraZeneca

Completed

Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age

Hypertension

United States, Hungary, Slovakia, Belgium
AstraZeneca

Completed

Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age

Pediatric Hypertension

United States, Hungary, Slovakia, Belgium
EnnovaBio Australia Pharmaceuticals Pty Ltd

Completed

A First-in-human Single Ascending Dose/Multiple Ascending Dose Study of ENN0403 in Healthy Subjects

Healthy

Australia
University of Arizona
Texas A&M University

Completed

A Grapefruit Feeding Trial in Healthy, Overweight Adults

Obesity | Weight Loss | Cardiovascular Risk Factors

United States
AstraZeneca
Scentryphar Clinical Research; Cori Analyticals; Clínica São Lucas, Hospital... and other collaborators

Completed

Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific Meal

Healthy

Brazil
Montreal Heart Institute
AstraZeneca

Completed

A Pharmacogenomic Study of Candesartan in Heart Failure

Heart Failure

Canada
AstraZeneca

Completed

Candesartan Effect in Second Stage Arterial Hypertension (CAESAR)

Stage II Hypertension

Korea, Republic of
AstraZeneca

Completed

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo

Hypertension

Russian Federation, Latvia, Romania, Slovakia, Belgium, Malta
HK inno.N Corporation

Completed

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy

Essential Hypertension

Korea, Republic of
The Netherlands Cancer Institute
Roche Pharma AG; AstraZeneca

Completed

Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity

Breast Cancer

Netherlands
Boryung Pharmaceutical Co., Ltd
Pusan National University Hospital; Ulsan University Hospital; Daegu Catholic... and other collaborators

Completed

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

Hypertension

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

Essential Hypertension

Korea, Republic of
The Japanese Society of Hypertension

Unknown

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients

Cardiovascular Diseases | Hypertension

Japan
PD Dr. Grégoire Wuerzner
Swiss National Science Foundation

Completed

Renal Response to Lower Body Negative Pressure in Pre-hypertensive States

Hypertension | Obesity | White Coat Hypertension | Resistant Hypertension

Switzerland
Cerevel Therapeutics, LLC

Recruiting

A Study Evaluating the Pharmacokinetics and Relative Bioavailability of Emraclidine Immediate-Release Tablets in Healthy Adult Participants

Healthy Participants

United States
Takeda

Completed

Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)

Hypertension

Japan
Yonsei University

Completed

Effect of Candesartan in Alcoholic Liver Fibrosis

Alcoholic Liver Disease

Korea, Republic of
Takeda

Completed

Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"

Hypertension
Bayer

Completed

Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions

Hypertension, Essential

Germany
Institut de Recherches Cliniques de Montreal
Ottawa Hospital Research Institute

Completed

Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.

Hypertension

Canada
Third Military Medical University

Completed

A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients (HOT-ACME)

Hypertension | Obesity

China
Dong-A ST Co., Ltd.

Completed

Study of Motilitone to Treat Functional Dyspepsia

Dyspepsia

United States
HK inno.N Corporation

Completed

Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets (REVERT-K)

Hypertension, Hyperlipidemia

Korea, Republic of
Timothy Roberts
Simons Foundation; Clinical Research Associates, LLC

Completed

MEG Study of Acute STX209 Effects in ASD

Autism Disorder

United States
EMS

Withdrawn

Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control

Essential Arterial Hypertension
HanAll BioPharma Co., Ltd.

Unknown

Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)

Hypertension
Takeda

Completed

Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.

Hypertension | Obesity

Germany
Takeda

Completed

Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension

Hypertension

Ukraine, Germany
Technische Universität Dresden

Completed

Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.

Healthy Subjects

Germany
Baylor College of Medicine
National Institute on Drug Abuse (NIDA)

Terminated

A Pilot Study of Candesartan as a Treatment for Cocaine Dependence

Cocaine Dependence

United States
Saitama Medical University

Completed

Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients

Cardiovascular Disease
Augusta University
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Adiposity and Endothelin Receptor Function (END-RF)

Hypertension

United States
Takeda

Completed

Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension

Essential Hypertension
Abbott
Datamap; ClinIntel; Catalent; Nuvisan

Withdrawn

A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2

Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2

Germany, Spain
Tisento Therapeutics

Not yet recruiting

A Phase 2b Study of Zagociguat in Patients With MELAS (PRIZM)

Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)

United States, Australia, Italy, Germany, Canada, United Kingdom
Institut für Pharmakologie und Präventive Medizin

Completed

Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine (Sevicontrol1)

Hypertension

Germany
Washington University School of Medicine
University of Sydney; ACCESS Community Health Network

Active, not recruiting

Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension (QUARTET USA)

Hypertension

United States

3

Subscribe